Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T1MP
|
|||
Former ID |
DIB004073
|
|||
Drug Name |
Lurosetron
|
|||
Synonyms |
Lurosetron mesylate; GR-87442; GR-87442N
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Vomiting [ICD-11: MD90; ICD-10: R11; ICD-9: 787] | Discontinued in Phase 2 | [1] | |
Company |
Glaxo Wellcome plc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H17FN4O
|
|||
Canonical SMILES |
CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=C(N3C)C(=CC=C4)F
|
|||
InChI |
1S/C17H17FN4O/c1-10-13(20-9-19-10)8-22-7-6-14-15(17(22)23)11-4-3-5-12(18)16(11)21(14)2/h3-5,9H,6-8H2,1-2H3,(H,19,20)
|
|||
InChIKey |
NUMKWGDDRWJQMY-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 128486-54-4
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | 5-HT 3 receptor (5HT3R) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002948) | |||
REF 2 | US patent application no. 7,932,267, Use of α-glucosidase inhibitors to treat alphavirus infections. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.